International Cancer Imaging Society

International Cancer Imaging Society Meeting and 15th Annual Teaching Course

Mon 05 Oct 2015 - Wed 07 Oct 2015

Clore Education Centre, British Museum, London, UK

Targeting cancer with imaging 

Registration is now open, click here to reserve your place.

Further information can be found here.

Submit your abstract here.



» Other Meetings

Interactive Workshops

Masterclass in Imaging of Gynaecological Cancers

Mon 11 May 2015  

Stockholm, Sweden

These one day teaching courses are limited to 40 participants, each with their own imaging workstation and content delivered through lectures and hands-on case based learning.

 

» Register now! 

Cancer Imaging Journal

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.

 

 

» President's Message 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 15% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

Registration opens for London 2015
27 February 2015

Registration opens for London 2015


Prof. Andrea Rockall, President for 2015 has put together a really exciting programme for our annual teaching course.  

Keynote lectures
Microbubbles: From cancer diagnosis to theranostics
MR/PET imaging: Future directions

Plenary sessions
Structured reporting and decision support

» Read more

A really enjoyable, informative and fun three days in a beautiful town.

KP | Royal Surrey Hospital, Guildford, UK

I would like to thank all the Faculty for the superb lectures delivered on the day and Dr Koh for an exceptionally well-organised meeting. The content, pace of lectures and the discussions were all extremely useful - my knowledge has improved significantly and I have no doubt my practice and reporting skills will further improve by using the material provided.

IM | Cambridge, UK

I am so very happy I came to ICIS this year, my first time.  Some of the talks were truly “life changing”.  I will gladly try to implement things I heard into my daily practice.  This conference showed me again what an exciting job I have and that here at ICIS I can acquire tools to truly make a difference.  Thank you!  Becoming a member of ICIS is a must!

EP | Germany

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.






Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Smokers underestimate risks of a few cigarettes: Survey shows that many live in 'denial' of the real risks

Published: Fri, 17 Apr 2015 13:00:00 GMT

Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at...

Genetic variability may help predict tumor aggressiveness and treatment success

Published: Fri, 17 Apr 2015 10:00:00 GMT

A new method that measured genetic variability in tumor cells from patients with head and neck cancer found high scores correlated with lower patient survival.

New liver cancer treatment approved for use in Europe

Published: Fri, 17 Apr 2015 09:00:00 GMT

A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety.

Early use of palliative care in cancer improves patients' lives, outcomes for caregivers

Published: Fri, 17 Apr 2015 08:00:00 GMT

A new randomized clinical trial with Dartmouth investigators Kathleen Lyons, ScD, Tor Tosteson, ScD, Zhigang Li, PhD, and collaborators has noted significant improvement in several measures among...

Anti-fungal drug shows promise as potential new cancer treatment

Published: Fri, 17 Apr 2015 08:00:00 GMT

A common anti-fungal treatment has joined the ranks of drugs that may be suitable for use in treating cancer, according to research from the Repurposing Drugs in Oncology (ReDO) project published...

Tumor-only genetic sequencing may misguide cancer treatment in nearly half of all patients

Published: Fri, 17 Apr 2015 08:00:00 GMT

A study by Johns Hopkins scientists strongly suggests that sequencing tumor genomes for clues to genetic changes might misdirect treatment in nearly half of all patients unless it is compared first...

Racial disparity in cancer mortality is narrowing, suggests new study

Published: Fri, 17 Apr 2015 08:00:00 GMT

Cancer mortality remains significantly elevated among African Americans. Between 2000 and 2010, overall mortality from cancer decreased faster among African American women and men than among...

PharmaMar to present data on anticancer candidates PM1183 and plitidepsin at the AACR 2015

Published: Fri, 17 Apr 2015 07:00:00 GMT

American Association for Cancer Research Annual Meeting April 18-22, 2015 Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic effect...

African-American men at greater risk of prostate cancer, study finds

Published: Fri, 17 Apr 2015 07:00:00 GMT

Compared with non-Hispanic white men, obesity presented a higher prostate cancer risk and may be 'uniquely harmful' to African-American men, a new study finds.

Nanoparticles at specific temperature stimulate antitumor response

Published: Fri, 17 Apr 2015 07:00:00 GMT

Dartmouth researchers identify precise heat to boost immune system against cancer tumorsSeeking a way to stimulate antitumor responses via the immune system, Steven Fiering, PhD, of Norris Cotton...

High fidelity: SLU researcher finds keys to genome integrity

Published: Thu, 16 Apr 2015 08:00:00 GMT

Four-way junctions hold answers to clearing DNA replication road blocksMaintaining the stability and the correct sequence of our genetic information is vital to the accurate transmission of our...

CNIO experts identify an oncogene regulated by nutrients

Published: Thu, 16 Apr 2015 07:00:00 GMT

Scientists from the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Center (CNIO), led by Nabil Djouder, have discovered that the MCRS1 protein, in response to an...

Genetically engineered Salmonella promising as anti-cancer therapy

Published: Thu, 16 Apr 2015 07:00:00 GMT

A new study has demonstrated that genetically modified Salmonella can be used to kill cancer cells.

The cost and quality of cancer care in Health Affairs' April issue

Published: Thu, 16 Apr 2015 07:00:00 GMT

1. Cancer Mortality Reductions Were Greatest Among Countries Where Cancer Care Spending Rose The Most, 1995-2007.Warren Stevens of Precision Health Economics, Dana P.

Immunotherapy fights cancer better with both arms of the immune system, say researchers

Published: Wed, 15 Apr 2015 10:00:00 GMT

The idea of fighting cancer with immunotherapy is to trigger the immune system. Now, a new study suggests recruiting both the innate and the adaptive immune system works best.

Promising developments in tackling resistance to blood cancer drugs

Published: Wed, 15 Apr 2015 09:00:00 GMT

A drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton.

New biomarker for uterine cancer discovered

Published: Wed, 15 Apr 2015 09:00:00 GMT

Researchers at Uppsala University have, together with researchers from Turku and Bergen, discovered a new biomarker which makes it possible to identify women with uterine cancer who have a high...

Study finds testicular cancer link for muscle-building supplements

Published: Wed, 15 Apr 2015 08:00:00 GMT

Men who reported taking muscle-building supplements, such as pills and powders with creatine or androstenedione, reported a significantly higher likelihood of having developed testicular cancer than...

Smartphone-based device could provide rapid, low-cost molecular tumor diagnosis

Published: Wed, 15 Apr 2015 07:00:00 GMT

A device developed by Massachusetts General Hospital investigators may bring rapid, accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology.

Pitt cancer virology team reveals new pathway that controls how cells make proteins

Published: Wed, 15 Apr 2015 07:00:00 GMT

A serendipitous combination of technology and scientific discovery, coupled with a hunch, allowed University of Pittsburgh Cancer Institute (UPCI) researchers to reveal a previously invisible...